These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 11346179)

  • 1. Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1.
    Mishima M; Xuan X; Shioda A; Omata Y; Fujisaki K; Nagasawa H; Mikami T
    J Vet Med Sci; 2001 Apr; 63(4):433-8. PubMed ID: 11346179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
    Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
    Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
    Lau YL; Fong MY
    Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii.
    Petersen E; Nielsen HV; Christiansen L; Spenter J
    Vaccine; 1998 Aug; 16(13):1283-9. PubMed ID: 9682392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles.
    Chuang SC; Ko JC; Chen CP; Du JT; Yang CD
    Parasit Vectors; 2013 Feb; 6():34. PubMed ID: 23398973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic characterization of the chimeric surface antigen 1 and 2 (SAG1/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris.
    Lau YL; Thiruvengadam G; Lee WW; Fong MY
    Parasitol Res; 2011 Sep; 109(3):871-8. PubMed ID: 21455621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.
    Igarashi M; Kano F; Tamekuni K; Machado RZ; Navarro IT; Vidotto O; Vidotto MC; Garcia JL
    Exp Parasitol; 2008 Mar; 118(3):386-92. PubMed ID: 18154953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice.
    Liu Q; Gao S; Jiang L; Shang L; Men J; Wang Z; Zhai Y; Xia Z; Hu R; Zhang X; Zhu XQ
    Microbes Infect; 2008 Oct; 10(12-13):1355-62. PubMed ID: 18761418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice.
    Zhang D; Jiang N; Chen Q
    Vaccine; 2019 Feb; 37(8):1118-1125. PubMed ID: 30670302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins.
    Nie H; Fang R; Xiong BQ; Wang LX; Hu M; Zhou YQ; Zhao JL
    Vet Parasitol; 2011 Sep; 181(2-4):215-21. PubMed ID: 21632181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.
    Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H
    Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial protection against tissue cysts formation in pigs vaccinated with crude rhoptry proteins of Toxoplasma gondii.
    Garcia JL; Gennari SM; Navarro IT; Machado RZ; Sinhorini IL; Freire RL; Marana ER; Tsutsui V; Contente AP; Begale LP
    Vet Parasitol; 2005 May; 129(3-4):209-17. PubMed ID: 15845275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological role of surface Toxoplasma gondii antigen in development of vaccine.
    Liu KY; Zhang DB; Wei QK; Li J; Li GP; Yu JZ
    World J Gastroenterol; 2006 Apr; 12(15):2363-8. PubMed ID: 16688826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A.
    Lee YH; Shin DW; Lee JH; Nam HW; Ahn MH
    Yonsei Med J; 2007 Jun; 48(3):396-404. PubMed ID: 17594146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice.
    Han Y; Zhou A; Lu G; Zhao G; Wang L; Guo J; Song P; Zhou J; Zhou H; Cong H; He S
    BMC Infect Dis; 2017 Jan; 17(1):59. PubMed ID: 28077075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
    Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
    Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice.
    Gong P; Cao L; Guo Y; Dong H; Yuan S; Yao X; Ren W; Yao L; Xu Z; Sun Q; Zhang X
    Exp Parasitol; 2016 Jul; 166():131-6. PubMed ID: 27059254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.